Pemphigus Herpetiformis: Association With Malignancies and Therapeutic Challenges
Actas Dermo-Sifiliográficas · 2027-02 · 118 (2) · 104764
DOI: 10.1016/j.ad.2026.104764 ↗Kurz gefasst
Fallbericht in der Zeitschrift Actas Dermo-Sifiliográficas, 2027-02. Verfasst von M Brufau-Cochs und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This case series examines the histopathological, immunological, and therapeutic characteristics of 7 patients diagnosed with pemphigus herpetiformis (PH) at a tertiary hospital between 1989 and 2025. The most common clinical manifestation was pruritic annular lesions. Direct immunofluorescence was positive in all cases, whereas serological testing (enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting) performed at 2 independent referral centers detected anti-desmoglein 1 antibodies in only 2 patients, with negative antigen-specific results in the remaining patients. An association between PH and malignancy was observed in 43% of cases, particularly with lung cancer, including the first reported case of PH associated with pancreatic cancer. These findings underscore the importance of recognizing this potential association to optimize patient management. Regarding treatment, conventional therapies such as corticosteroids and dapsone showed variable efficacy, whereas rituximab appeared less effective than in other pemphigus variants.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
- Department of Pathology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
- Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
- Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Department of Dermatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. Electronic address: jmmascaro_galy@ub.edu.
Zitieren
APA
Brufau-Cochs, M., Giavedoni, P., Bosch-Amate, X., Riera-Monroig, J., García-Herrera, A., Ishii, N., Hashimoto, T., Iranzo, P., & Mascaró-Galy, J. M. (2027). Pemphigus Herpetiformis: Association With Malignancies and Therapeutic Challenges. Actas Dermo-Sifiliográficas, 118(2), 104764. https://doi.org/10.1016/j.ad.2026.104764
Vancouver
Brufau-Cochs M, Giavedoni P, Bosch-Amate X, Riera-Monroig J, García-Herrera A, Ishii N, et al. Pemphigus Herpetiformis: Association With Malignancies and Therapeutic Challenges. Actas Dermo-Sifiliográficas. 2027;118(2):104764. doi:10.1016/j.ad.2026.104764
BibTeX
@article{BrufauCochs2027,
author = {Brufau-Cochs, M and Giavedoni, P and Bosch-Amate, X and Riera-Monroig, J and García-Herrera, A and Ishii, N and Hashimoto, T and Iranzo, P and Mascaró-Galy, J M},
title = {Pemphigus Herpetiformis: Association With Malignancies and Therapeutic Challenges},
journal = {Actas Dermo-Sifiliográficas},
year = {2027},
volume = {118},
number = {2},
pages = {104764},
doi = {10.1016/j.ad.2026.104764}
}
EUVIMED